Bosses Have a New Headache: How Long Should Sick Workers Isolate?

Amid staffing shortages, companies are weighing conflicting guidance on when employees who have tested positive for the coronavirus can safely return to work.

#airlines-for-america, #brooklyn-nyc, #brown-university, #centers-for-disease-control-and-prevention, #city-practice-group-of-new-york-citymd, #coronavirus-2019-ncov, #coronavirus-omicron-variant, #delta-air-lines-inc, #doordash-mobile-app, #harvard-university, #hochul-kathleen-c, #jetblue-airways-corporation, #jha-ashish-1970, #merckcompany-inc, #national-football-league, #pfizer-inc, #quarantines, #scripps-research-institute, #society-for-human-resource-management, #target-corporation, #workplace-hazards-and-violations

Merck’s Covid Pill Cleared by FDA for High-Risk Adults

The F.D.A. said the drug was not a preferred treatment, but could be used when alternate treatment options were “not accessible or clinically appropriate.”

#coronavirus-omicron-variant, #food-and-drug-administration, #merckcompany-inc, #molnupiravir-drug, #united-states

F.D.A. Clears Merck’s Covid Pill for High-Risk Adults

The F.D.A. said the drug could be used when alternate treatment options were “not accessible or clinically appropriate.”

#coronavirus-omicron-variant, #food-and-drug-administration, #merckcompany-inc, #molnupiravir-drug, #united-states

Merck’s Covid Pill Might Pose Risks for Pregnant Women

Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.

#birth-defects, #coronavirus-2019-ncov, #dna-deoxyribonucleic-acid, #drugs-pharmaceuticals, #merckcompany-inc, #molnupiravir-drug, #pregnancy-and-childbirth, #research, #your-feed-science

Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel

The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.

#antibodies, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-delta-variant, #coronavirus-omicron-variant, #drugs-pharmaceuticals, #food-and-drug-administration, #merckcompany-inc, #molnupiravir-drug

F.D.A. Advisers Meets on Merck’s Covid Pill

If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.

#coronavirus-2019-ncov, #coronavirus-omicron-variant, #food-and-drug-administration, #merckcompany-inc, #molnupiravir-drug, #vaccination-and-immunization

Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?

The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.

#antibodies, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #income-inequality, #merckcompany-inc, #pfizer-inc, #tests-medical, #your-feed-health, #your-feed-science

Merck Says Its Covid Pill Is Less Effective in a Final Analysis

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

#clinical-trials, #coronavirus-2019-ncov, #merckcompany-inc, #molnupiravir-drug, #united-states

C.D.C. Says ‘Smallpox’ Vials Found in Lab Did Not Contain Disease-Causing Virus

In a new statement, the Centers for Disease Control and Prevention said the vials found in a Pennsylvania lab contained vaccinia, the virus used in the smallpox vaccine.

#centers-for-disease-control-and-prevention, #laboratories-and-scientific-equipment, #merckcompany-inc, #pennsylvania, #smallpox

U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People

The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #merckcompany-inc, #pfizer-inc, #stockpiling, #united-states-politics-and-government

Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries

The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard by the pandemic.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #medicines-patent-pool-foundation, #merckcompany-inc, #molnupiravir-drug, #paxlovid, #pfizer-inc, #third-world-and-developing-countries

Merck Will Share Formula for its Covid Pill With Poor Countries

The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #emory-university, #inventions-and-patents, #medicine-and-health, #medicines-patent-pool-foundation, #merckcompany-inc, #molnupiravir-drug, #ridgeback-biotherapeutics, #third-world-and-developing-countries

Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countries

Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.

#coronavirus-2019-ncov, #drugs-pharmaceuticals, #gates-bill-and-melinda-foundation, #international-trade-and-world-market, #merckcompany-inc, #molnupiravir-drug

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain for broad access to coronavirus drugs.

#africa, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #india, #merckcompany-inc, #molnupiravir-drug

Merck’s Covid Treatment Pill: What to Know About Molnupiravir

The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #merckcompany-inc, #molnupiravir

Merck Says It Has the First Antiviral Pill Found to Be Effective Against Covid

The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #food-and-drug-administration, #merckcompany-inc, #molnupiravir, #ridgeback-biotherapeutics

Merck Says It Has First Effective Antiviral Pill for Covid

The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #merckcompany-inc, #united-states

Biden Vows Enough Vaccine ‘for Every Adult American’ by End of May

The pharmaceutical giant Merck & Co. agreed to help manufacture Johnson & Johnson’s coronavirus vaccine, in a deal partly brokered by the White House.

#biden-joseph-r-jr, #coronavirus-2019-ncov, #defense-production-act, #drugs-pharmaceuticals, #factories-and-manufacturing, #food-and-drug-administration, #johnsonjohnson, #merckcompany-inc, #united-states-politics-and-government, #vaccination-and-immunization

How Merck’s Vaccine Lost the Covid Race

After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #merckcompany-inc, #vaccination-and-immunization, #your-feed-healthcare, #your-feed-science

Covid-19 Vaccines Offer Drug Makers Chance at Salvation, Financial and Beyond

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #curevac-gmbh, #drugs-pharmaceuticals, #glaxosmithkline-plc, #gorsky-alex, #johnsonjohnson, #merckcompany-inc, #novavax-inc, #pfizer-inc, #sanofi-sa, #vaccination-and-immunization

Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups

New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.

#amr-action-fund, #antibiotics, #drug-resistance-microbial, #drugs-pharmaceuticals, #eli-lilly-and-company, #johnsonjohnson, #merckcompany-inc, #roche-holding-ag, #start-ups, #your-feed-healthcare, #your-feed-science

Trump Narrows Search for Coronavirus Vaccine to Five Firms

The White House is eager to project progress, but the public-private partnership it has created still faces scientific hurdles, internal tensions and questions from Congress.

#astrazeneca-plc, #azar-alex-m-ii, #clinical-trials, #coronavirus-2019-ncov, #coronavirus-aid-relief-and-economic-security-act-2020, #drugs-pharmaceuticals, #health-and-human-services-department, #johnsonjohnson, #marks-peter, #merckcompany-inc, #moderna-inc, #oxford-university, #perna-gustave-f, #pfizer-inc, #public-private-sector-cooperation, #slaoui-moncef-m, #trump-donald-j, #vaccination-and-immunization